Abiraterone Acetate
Brand name: Abiraterone Acetate
Rank #53 of 500 drugs by total cost
$345.0M
Total Cost
122,643
Total Claims
$345.0M
Total Cost
2,762
Prescribers
$2,813
Cost per Claim
11,252
Beneficiaries
127,371
30-Day Fills
$125K
Avg Cost/Provider
44
Avg Claims/Provider
About Abiraterone Acetate
Abiraterone Acetate (sold as Abiraterone Acetate) was prescribed 122,643 times by 2,762 Medicare Part D providers in 2023, costing the program $345.0M. At $2,813 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 50 | Apalutamide (Erleada) | $369.2M | 24,956 |
| 51 | Secukinumab (Cosentyx Sensoready (2 Pens)) | $347.7M | 45,496 |
| 52 | Upadacitinib (Rinvoq) | $346.0M | 51,469 |
| 53 | Abiraterone Acetate (Abiraterone Acetate) | $345.0M | 122,643 |
| 54 | Icosapent Ethyl (Vascepa) | $334.9M | 692,252 |
| 55 | Cariprazine Hcl (Vraylar) | $329.1M | 226,854 |
| 56 | Albuterol Sulfate (Albuterol Sulfate Hfa) | $312.2M | 7,904,120 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology